In vitro investigation of the indirect pathogenicity of beta-lactamase-producing microorganisms in the nasopharyngeal microflora

International Journal of Pediatric Otorhinolaryngology

Volumn 69, Issue 4, 2005, Pages 479-485

  Kaieda, Satoru ^a,b   Yano, Hisakazu ^c   Okitsu, Naohiro ^b,c   Hosaka, Yoshio ^b   Okamoto, Ryoichi ^b   Inoue, Matsuhisa ^c   Takahashi, Haruo ^a  

^a NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

^b KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Beta lactamase; Indirect pathogenicity; Nasopharyngeal microflora

Indexed keywords

AMOXICILLIN; BETA LACTAMASE; CEFACLOR; CEFDITOREN; CEFTRIAXONE; CEPHALOSPORIN; CLAVULANIC ACID; ERYTHROMYCIN; FROPENEM; IMIPENEM; PENICILLIN G; VANCOMYCIN;

ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL CELL; BACTERIAL FLORA; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; BACTERIUM CULTURE; COLONY FORMING UNIT; CONTROLLED STUDY; HAEMOPHILUS PARAINFLUENZAE; HUMAN; MINIMUM INHIBITORY CONCENTRATION; MORAXELLA CATARRHALIS; NASOPHARYNX; NONHUMAN; PATHOGENICITY; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; STREPTOCOCCUS PNEUMONIAE;

EID: 14844331411     PISSN: 01655876     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijporl.2004.11.013     Document Type: Article

References (21)

1. W.E. Sanders Jr., and C.C. Sanders Inducible beta-lactamases; clinical and epidemiologic implications for use of newer cephalosporins Rev. Infect. Dis. 10 1988 830 838
2. R. Hakenbeck, M. Tarpay, and A. Tomasz Multiple changes of penicillin binding proteins in penicillin-resistant clinical isolates of Strepotococcus pneumoniae Antimicrob. Agents Chemother. 17 1980 364 371
3. P.M. Mendelman, D.O. Chaffin, and G. Kalaitzoglou Penicillin binding proteins and ampicillin resistance in Haemophilus influenzae J. Antimicrob. Chemother. 25 1990 525 534
4. J.H. Jorgensen, G.V. Doern, L.A. Maher, A.W. Howell, and J.S. Redding Antimicrobial resistance among respiratory isolates of Haemophilus influenzae, Moraxella Catarrhalis, and Streptococcus pneumoniae in the United States Antimicrob. Agents Chemother. 34 1990 2075 2080
5. J.L. Maddocks "Indirect pathogenicity"of penicillinase producing enterobacteria in chronic bronchial infections Lancet 19 1969 793 795
6. R. Berner, R.F. Schumacher, M. Brondis, and J. Forster Clonization and infection with Moraxella catarrhalis in children Eur. J. Cln. Microbiol. Infect. Dis. 15 1996 506 509
7. H. Yano, M. Suetake, A. Kuga, R. Okamto, T. Kobayashi, and M. Inoue Pulsed-field gel electrophoresis analysis of nasopharyngeal flora in children attending day care center J. Clin. Microbiol. 38 2000 625 629
8. I. Brook Penicillin failure and copathogenicity in streptococcal pharyngotonsillitis J. Fam. Pract. 38 1994 175 179
9. J.A. Pollard, R.J. Wallace, D.R. Nash, J.I. Luman, and R.W. Wilson Incidence of Branhamella catarrhalis in the sputa of patients with chronic lung disease Drugs 31 1986 103 108
10. J.K. Wardle Branhamella catarrhalis as an indirect pathogen Drugs 3 Suppl. 1986 93 96
11. National Committee for Clinical Laboratory Standards Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically Approved Standard M7-M3 fourth ed. 1997 National Committee for Clinical Laboratory Standards Wayne, PA
12. National Committee for Clinical Laboratory Standards, Performance for Antimicrobial Susceptibility Testing, 9th Informational Supplement, M100-S9, vol. 18, no. 1, National Committee for Clinical Laboratory Standards, Wayne, PA, 2000.
13. A. Percival, J.E. Corkill, J. Rowland, and R.B. Sykes Pathogenicity and beta-lactamase production by Branhamella (Neisseria) catarrhalis Lancet ii 1977 1175
14. G.V. Doern, A.B. Brueggemann, G. Pierce, T. Hogan, H.P. Holley, and A. Rauch Prevalence of antimicrobial resistance among 723 outpatient clinical isolates of Moraxella catarrhalis in the United States in 1994 and 1995: results of 30-center national surveillance study Antimicrob. Agents Chemother. 40 1996 2884 2886
15. D.J. Hoban, G.V. Doern, A.C. Fluit, M. Roussel-Delvallez, and R.N. Jones Worldwide prevalence of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the SENTRY Antimicrobial Surveillance Program Clin. Infect. Dis. 15 Suppl. 2 2001 81 93
16. H.J. Bootsma, H. Van Dijke, J. Verhoef, A. Fleer, and F.R. Mooi Molecular characterization of the BRO beta-lactamases of Moraxella (Branhamella) catarrhalis Antimicrob. Agents Chemother. 40 1996 966 972
17. R.J. Wallace, J.R. Vincent, V.A. Steingrube, D.R. Nash, D.G. Hollis, and C. Flanagan BRO beta-lactamases of Branhamella catarrhalis and Moraxella subgenus Moraxella including evidence for chromosomal beta-lactamase transfer by conjugation in B. catarrhalis, M. nonliquefaciens, and M. lacunata Antimicrob. Agents Chemother. 33 1989 1845 1854
18. J.M. Ling, H. Khin-Thi-Oo, Y.W. Hui, and G.L. French Antimicrobial susceptibilities of Haemophilus species in Hong Kong J. Infect. 19 1989 135 142
19. D.W. Scheifele, and S.J. Fussell Frequency of ampicillin-resistant Haemophilus parainfluenzae in children J. Infect. Dis. 143 1981 495 498
20. D. Scheifele, S.J. Fussell, and M.C. Roberts Characterization of ampicillin-resistant Haemophilus parainfluenzae Antimicrob. Agents Chemother. 21 1982 734 739
21. C. Hol, E. Van Dijke, C.M. Verduim, J. Verhoef, and H. Van Dijke Experimental evidence for Moraxella-induced penicillin neutralization in pneumococcal pneumonia J. Infect. Dis. 170 1994 1613 1616